QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study.
Victoria Mazoteras PardoRicardo Becerro de Bengoa-VallejoMarta Elena Losa IglesiasEva María Martínez-JiménezCésar Calvo LoboCarlos Romero MoralesDaniel López-LópezPatricia Palomo-LópezPublished in: Journal of medical Internet research (2020)
This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.